説明
Experimental design and treatment protocol for evaluating erinacine A-enriched Hericium erinaceus mycelium in APP/PS1 transgenic mice, outlining the dosing regimen and assessment timeline for Alzheimer's disease-related pathologies.
Figure 1
FlowchartSource Paper
Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice.Cite This Figure
![Figure 1: Experimental design and treatment protocol for evaluating erinacine A-enriched Hericium erinaceus mycelium in APP/PS1 transgenic mice, outlining the dosing regimen and assessment timeline for Alzheimer's disease-related pathologies.]() > Source: Tzeng Tsai-Teng et al. "Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease." *Journal of biomedical science*, 2016. PMID: [27350344](https://pubmed.ncbi.nlm.nih.gov/27350344/)
<figure> <img src="" alt="Experimental design and treatment protocol for evaluating erinacine A-enriched Hericium erinaceus mycelium in APP/PS1 transgenic mice, outlining the dosing regimen and assessment timeline for Alzheimer's disease-related pathologies." /> <figcaption>Figure 1. Experimental design and treatment protocol for evaluating erinacine A-enriched Hericium erinaceus mycelium in APP/PS1 transgenic mice, outlining the dosing regimen and assessment timeline for Alzheimer's disease-related pathologies.<br> Source: Tzeng Tsai-Teng et al. "Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease." <em>Journal of biomedical science</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27350344/">27350344</a></figcaption> </figure>